id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2013-0002-0001,DEA,DEA-2013-0002,Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV,Proposed Rule,,2013-03-25T04:00:00Z,2013,3,2013-03-25T04:00:00Z,2013-04-25T03:59:59Z,2013-04-24T01:05:32Z,2013-06651,0,0,09000064812416e6